| Price | 0.185p on 04-09-2026 at 18:15:13 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.20p |
| Sell | 0.17p |
| Last Trade: | Sell 190,839.00 at 0.1834p |
| Day's Volume: | 1,195,299 |
| Last Close: | 0.185p |
| Open: | 0.185p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.185p - 0.185p |
| 52wk Range: | 0.18p - 0.265p |
| Market Capitalisation: | £3.98m |
| VWAP: | 0.173506p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 190,839 | 0.1834p | Ordinary |
12:48:42 - 04-Sep-26 |
| Buy* | 3,795 | 0.20p | SI Trade |
09:33:05 - 04-Sep-26 |
| Buy* | 665 | 0.20p | SI Trade |
09:33:05 - 04-Sep-26 |
| Sell* | 900,000 | 0.1715p | Ordinary |
08:29:46 - 04-Sep-26 |
| Sell* | 100,000 | 0.1715p | Ordinary |
08:29:14 - 04-Sep-26 |
| Sell* | 2,777,777 | 0.18p | Ordinary |
16:23:02 - 03-Sep-26 |
| Sell* | 1,000,000 | 0.18p | Ordinary |
14:42:55 - 03-Sep-26 |
| Buy* | 11,881 | 0.20p | Ordinary |
13:31:21 - 03-Sep-26 |
| Sell* | 224,849 | 0.18p | Ordinary |
13:31:10 - 03-Sep-26 |
| Sell* | 338,715 | 0.18p | Ordinary |
13:30:44 - 03-Sep-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 20th Aug 2026 4:13 pm | RNS | Proposed Placing & Subscription to raise £1.05m |
| 24th Jun 2026 4:34 pm | RNS | Holding(s) in Company |
| 26th May 2026 2:40 pm | RNS | Holding(s) in Company |
| 15th May 2026 12:43 pm | RNS | Holding(s) in Company |
| 15th May 2026 7:00 am | RNS | Holding(s) in Company |
| 14th May 2026 7:00 am | RNS | Positive Ox-1 tox data in addiction programme |
| 21st Apr 2026 7:00 am | RNS-R | Investor Webinar |
| 20th Apr 2026 7:00 am | RNS | Successful GMP Manufacture Advances Ox-1 to Clinic |
| 16th Apr 2026 7:00 am | RNS | New Manufacturing Process Patent for Ox-1 |
| 14th Apr 2026 7:00 am | RNS | Non-Binding Proposal to Acquire TheraCryf’s Assets |
